Needham analysts said Teleflex’s inability to secure a price above the low end of their expectations could reflect “the continued poor performance of UroLift.” ...

Medical device maker Teleflex said on Tuesday it would sell three units for a combined $2.03 billion, as it sharpens its focus on its critical care and hospital businesses. Shares of the company were ...

Teleflex (TFX) has agreed to sell its acute care, interventional urology and OEM businesses to two buyers for a combined $2.03 billion in cash, subject to adjustments. Intersurgical will acquire the ...

Teleflex said it plans to sell three of its businesses for a total of $2.03 billion in cash as it continues to focus on its core markets.

Shares of medical technology company Teleflex (NYSE:TFX) fell 22.9% in the morning session after the company reported disappointing fourth-quarter results, with revenue missing expectations by a ...

Wondering if Teleflex is a beaten down opportunity or a value trap at today’s price? Let us walk through what the numbers are really saying about the stock. After sliding 3.8% over the last week, ...

CAUTION: Federal (USA) law restricts these devices for sale or use by or on the order of a physician.

Teleflex Incorporated presented new clinical data at the 2025 American Urological Association Annual Meeting, highlighting the UroLift™ System as a leading minimally invasive treatment for benign ...

In the last three months, 5 analysts have published ratings on Teleflex (NYSE:TFX), offering a diverse range of perspectives from bullish to bearish. The following table provides a quick overview of ...

Teleflex stock (NYSE: TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a 31% fall this year, underperforming the broader S&P500 index, ...

The what, where, when, why and how was known, but the who behind a new, roughly 150-employee medical device research facility being built on former VF Outlet Center property in Wyomissing was the big ...

The stock price of Teleflex, best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a decline of 12% over the last month, while it was down over 4% ...